Trends in Endocrinology & Metabolism
ReviewApoM: gene regulation and effects on HDL metabolism
Section snippets
ApoM, a unique apolipoprotein in blood
Apolipoprotein M (apoM) is a recently discovered ∼25 kDa lipoprotein-associated plasma protein that is synthesized mainly in the liver and, to a smaller degree, in the kidney [1]. Most human apoM in blood is part of high-density lipoproteins (HDLs), but apoM is also found in other lipoprotein classes, including chylomicrons 1, 2. However, the putative impact of apoM on the metabolism of chylomicron and low-density lipoprotein (LDL) metabolism has not yet been explored. The mean molar plasma
ApoM in the kidney
Liver-derived apoM is mainly secreted to the plasma and integrated in plasma lipoproteins, whereas kidney-derived apoM is probably metabolized in the kidney proximal tubule. Thus, kidney-derived apoM binds the multi-ligand receptor megalin in the proximal tubular epithelium in the kidney (Figure 1). Mice lacking expression of megalin in the proximal tubule secrete apoM in the urine, whereas apoM is normally undetectable in the urine [9]. These data indicate that kidney-derived apoM is secreted
Regulation of apoM gene expression
ApoM gene expression is directly regulated by transcription factors that, among many other factors, control hepatic lipid metabolism: hepatic nuclear factor (HNF)-1α, liver receptor homolog (LRH)-1 and forkhead box A2 (Foxa2) 10, 11, 12 (Figure 2). This might indicate that apoM is linked with lipid and glucose homeostasis.
HNF-1α is a master regulator of hepatic gene expression, and HNF-1α-deficient mice have severe abnormalities in kidney, pancreas and liver function, including defective bile
Role of apoM in murine HDL metabolism
The impact of apoM on cholesterol and lipoprotein metabolism has, so far, been investigated mainly in genetically modified mouse models. Overexpression of apoM in transgenic mice, either with an adenoviral construct or constitutively, increases plasma cholesterol 32, 33. The increase in plasma cholesterol concentration was ∼20% (statistically significant) in mice overexpressing human apoM approximately tenfold, and complete knockout of the apoM gene in mice reduced plasma cholesterol by ∼20%
Effect of apoM on atherosclerosis in mice
Increased plasma concentrations of mouse and human apoM reduced development of early atherosclerotic lesions in the setting of LDL-receptor deficiency 32, 33. Notably, modest apoM overexpression did not affect plasma levels of the atherogenic VLDL and LDL lipoproteins in LDL-receptor-deficient mice, indicating that apoM might have effects on atherosclerosis beyond total plasma lipoprotein levels. Thus, it will be interesting to examine the effect of apoM deficiency on atherosclerosis.
The
Correlation between apoM and cholesterol levels in human plasma
Insight into the effect of apoM in humans stems from studies of isolated apoM-containing HDL and LDL particles isolated by immune-affinity methods and from measuring plasma apoM concentrations because there are no known mutations in the apoM gene that lower or increase apoM expression in humans. Similar to normal HDL, isolated apoM-containing HDL is heterogeneous in size, charge and density [2]. However, apoM-containing HDL is slightly more effective in mobilising cholesterol and slightly more
Concluding remarks
Studies using genetically modified mice have provided novel insight into the regulation and putative roles of apoM in HDL metabolism and atherosclerosis. ApoM is regulated by transcription factors that are also linked with hepatic glucose and lipid metabolism. Even though the biological role of apoM is unsettled, apoM seems to affect pre-β HDL formation. In addition, the recent data from mice with genetically altered apoM expression indicate that apoM has atheroprotective properties. Recent
Future directions
ApoM is a plasma lipoprotein that has been preserved during evolution and is even found in primitive organisms such as fish. There are recent indications that apoM is closely associated with plasma cholesterol in humans and that the apoM gene is regulated by transcription factors that also affect hepatic lipid and glucose metabolism. Because plasma cholesterol levels are important for human cardiovascular disease, it will be pertinent to unravel the mechanism of the association between apoM and
References (39)
- et al.
A novel human apolipoprotein (apoM)
J. Biol. Chem.
(1999) Isolation and characterization of human apolipoprotein M-containing lipoproteins
J. Lipid Res.
(2006)An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma
J. Lipid Res.
(2007)Apolipoprotein M associates to lipoproteins through its retained signal peptide
FEBS Lett.
(2008)The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma
J. Biol. Chem.
(2008)The lipocalin protein family: structural and sequence overview
Biochim. Biophys. Acta
(2000)Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis
FEBS Lett.
(2001)Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M
J. Lipid Res.
(2007)Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M
J. Biol. Chem.
(2008)Characterization of apoM in normal and genetically modified mice
J. Lipid Res.
(2004)
Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12α-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription
J. Biol. Chem.
The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor
J. Biol. Chem.
Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1
J. Biol. Chem.
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
Mol. Cell
Foxa2 integrates the transcriptional response of the hepatocyte to fasting
Cell Metab.
Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro
Biochim. Biophys. Acta
Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro
Biochem. Biophys. Res. Commun.
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice
J. Biol. Chem.
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
J. Lipid Res.
Cited by (32)
Apolipoprotein M, identified as a novel hepatitis C virus (HCV) particle associated protein, contributes to HCV assembly and interacts with E2 protein
2020, Antiviral ResearchCitation Excerpt :ApoM binds primarily to high-density lipoproteins (HDLs) in the plasma (Ren et al., 2015) and is required for prebeta-HDL formation. Studies indicated that ApoM participated in cholesterol efflux to HDL and protected against atherosclerosis (Nielsen et al., 2009; Wolfrum et al., 2005). And the likely roles of ApoM in health and disease has become more diverse after the discovery of sphingosine-1-phosphate as a ligand for ApoM (Borup et al., 2015).
Analysis of apolipoprotein multigene family in spotted sea bass (Lateolabrax maculatus) and their expression profiles in response to Vibrio harveyi infection
2019, Fish and Shellfish ImmunologyCitation Excerpt :Additionally, several Apos including ApoD, ApoF, ApoH, ApoL, ApoM, and ApoO classes, have been discovered and are regarded as atypical apolipoproteins based on their primary structures. The structures of atypical apolipoproteins show no similarity to exchangeable or non-exchangeable apolipoproteins, but they are also components of lipoprotein and are associated with lipid metabolism [7,8]. Apos have been extensively studied in humans (Homo sapiens), and a relationship between specific lipoproteins and cardiovascular disease is apparent [9,10].
Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier
2017, Biochimica et Biophysica Acta - Molecular and Cell Biology of LipidsHepatic apolipoprotein M (ApoM) overexpression stimulates formation of larger ApoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein
2014, Journal of Biological Chemistry